Modifier KX: What You Are Actually Attesting To

Modifier KX is unusual among billing modifiers because it has no fixed clinical meaning. It does not describe an anatomic site, a separate encounter, a repeat, or a component split. It is an attestation, and its content is supplied entirely by whatever coverage policy applies to the item or service on the claim line: the requirements specified in the applicable medical policy have been met, and the documentation exists to prove it.

That is why “when do I use KX” has no single answer, and why searching for one produces contradictory guidance. The real question is narrower and answerable: which policy is speaking on this claim line, what does it require, and can I show it?

The Decision Rule

Before appending KX, three things must be established, in order:

1. Identify the governing policy. KX is only meaningful with reference to a specific instrument — a Local Coverage Determination (LCD), a National Coverage Determination (NCD), a statutory threshold, or a contractor article. If you cannot name the policy the modifier is attesting to, you are not in a position to append it.
2. Confirm the criteria in that policy are actually met for this beneficiary, on this date, for this item. Not “usually met for this kind of patient” — met, here.
3. Confirm the documentation supporting those criteria already exists in the record and can be produced on request. KX asserts the documentation exists; it does not create it, and it does not defer it.

If all three hold, KX is appropriate. If the third fails, appending KX converts a coverage problem into a false-attestation problem.

The Two Contexts That Generate Most KX Traffic

KX behaves quite differently in the two settings where it is most common, and conflating them is the source of a great deal of confusion.

1. The outpatient therapy threshold

Section 50202 of the Bipartisan Budget Act of 2018 repealed the hard Medicare outpatient therapy caps but retained the former cap amounts as a KX modifier threshold — a dollar level of incurred expenses above which claims must carry KX as a confirmation that the services remain medically necessary and are justified by appropriate documentation. CMS states the CY 2026 threshold amounts as $2,480 for physical therapy and speech-language pathology services combined, and $2,480 for occupational therapy services. A separate, lower targeted medical review threshold of $3,000 (per the same statute, carrying forward a MACRA-era mechanism) determines which high-dollar episodes are eligible for selection into review. The thresholds are indexed and change; verify the current-year figures against CMS’s therapy services page before relying on them.

The Medicare Claims Processing Manual (Publication 100-04, Chapter 5, Section 10.3.3) sets out exactly what the modifier attests in this context. By appending KX, the provider is asserting that the services billed:

• are reasonable and necessary services that require the skills of a therapist;
• are justified by appropriate documentation in the medical record; and
• qualify for an exception under the automatic process.

The manual then adds the sentence that gives the modifier its teeth: “If this attestation is determined to be inaccurate, the provider/supplier is subject to sanctions resulting from providing inaccurate information on a claim.” KX is not a routing flag. It is a representation about the record.

There is also a claim-construction rule that trips people up on institutional claims. When the threshold is exceeded by at least one line, KX goes on all lines on that claim referring to the same threshold pairing — so if a PT line exceeds it, KX goes on the PT and SLP lines (which also carry GP or GN). Occupational therapy is tracked separately: if all the OT lines are below the threshold, KX does not go on any of them, even where KX is correctly used on the PT lines. It is all-or-none within a discipline pairing, not per-line judgement. The GN, GO and GP discipline modifiers continue to be required alongside KX; they answer a different question (which therapy discipline) and do not substitute for it.

2. DMEPOS and LCD-driven coverage criteria

For durable medical equipment, prosthetics, orthotics and supplies, KX means the supplier has confirmed the coverage criteria in the applicable DME MAC Local Coverage Determination are met and that documentation supporting medical necessity exists and is available on request. The list of LCDs that use KX is long and heterogeneous — positive airway pressure devices, power mobility devices, knee and ankle-foot orthoses, hospital beds, nebulizers, enteral and parenteral nutrition, therapeutic shoes for people with diabetes, speech generating devices, negative pressure wound therapy pumps, pressure reducing support surfaces, glucose monitors and testing supplies, among many others. Each imposes its own criteria. KX on a PAP claim and KX on a knee orthosis claim are attesting to entirely different sets of facts.

One frequently-cited wrinkle: the Glucose Monitors and Testing Supplies LCD documentation requirements direct that KX be appended to all claims for glucose monitors and testing supplies where the beneficiary is being treated with insulin injections, and that KX not be appended where they are not. That is an example of KX functioning as a required status indicator rather than an exception request — and an example of why “does this LCD use KX, and how” has to be checked policy by policy rather than assumed.

Other contexts

KX also appears in narrower national instructions. In PET oncologic imaging, for instance, the Claims Processing Manual uses the presence of KX on the professional component service as the signal distinguishing NaF-18 PET from PET with FDG in contractor processing. These one-off uses reinforce the same point: the modifier’s meaning is delegated to the policy it sits under.

What the Record Must Show

Because KX derives its content from the underlying policy, the documentation standard is derived too. There is no generic “KX documentation.” What is generic is the structure of what a reviewer will look for:

• Evidence keyed to the specific criteria. If the LCD requires a face-to-face encounter within a defined window, a specific diagnosis, a trial of a less costly alternative, or an objective measurement, the record needs each of those elements individually identifiable — not a general narrative from which they could be inferred.
• Dates that satisfy the policy’s timing rules. Many LCDs are as much about sequence and recency as about clinical facts. Documentation generated after the date of service to support a KX already submitted is a materially different thing from documentation that existed at the time.
• For therapy above the threshold: skilled-service justification, not volume justification. The manual’s standard is that the services require the skills of a therapist. A note recording that treatment continued does not establish that it needed a therapist.
• Retrievability. The attestation is that documentation “does exist” and is available on request. A record that cannot be produced within a contractor’s response window functions, on review, as a record that does not exist.

The Misuse That Triggers Denials and Audits

The dominant misuse pattern is blanket application — configuring KX to append automatically to a class of claims so that they stop denying. CMS guidance calls this out in unusually direct language. Chapter 5 states that it is only appropriate to append KX to a service that reasonably may exceed the threshold, and that use of the KX modifier when there is no indication that the threshold is likely to be exceeded is abusive — giving the example of low-cost services early in an episode with no evidence of a prior episode. Elsewhere the same chapter warns that routine use of KX for all patients with a given condition “will likely show up on data analysis as aberrant and invite inquiry.”

Three further patterns are worth naming:

1. KX as a denial workaround. Appending it after a claim denies, without going back to check whether the coverage criteria are actually met, is the exact behaviour the attestation language is written to deter.
2. KX where the policy does not call for it. On the DMEPOS side, an unnecessary or incorrect modifier commonly produces an unprocessable return rather than a denial — Noridian’s DME guidance notes that unprocessable claims returned with remark code MA130 carry no appeal rights and must be corrected and resubmitted. That is a workflow cost, not just a payment delay.
3. Systematised attestation without a systematised check. If your billing configuration can append KX but your intake workflow cannot confirm the LCD criteria, the two are out of alignment and every claim in that stream carries an unverified representation.

KX vs. Its Nearest-Confused Siblings

KX vs. GA — the two are opposite postures

This is the comparison worth internalising. KX says: the policy’s requirements are met, so this should be covered. GA says: I expect this to be denied as not reasonable and necessary, and I have issued an Advance Beneficiary Notice so the beneficiary can be held liable. They are mutually exclusive positions about the same claim line. If you find yourself considering both, you have not yet resolved the underlying coverage question — resolve it first. CASRAI covers the liability-shifting side in modifier GA and the waiver of liability and the notice mechanics in the Advance Beneficiary Notice guide.

KX vs. GZ, GX and GY

The G-series all describe expected non-coverage in different flavours: GZ (expected denial, no ABN issued — the provider stays liable), GX (voluntary notice issued for a statutorily excluded item), GY (statutorily excluded, no notice required). None of them assert that criteria are met; all of them assume they are not, or that coverage does not apply. KX belongs to a different family of claim.

KX vs. GN, GO and GP

In therapy billing these travel together on the same lines, which is why they get confused. GN, GO and GP identify the discipline (speech-language pathology, occupational therapy, physical therapy respectively) and are required regardless of threshold. KX identifies that the threshold has been passed and the medical-necessity attestation is being made. One is a category label; the other is a representation.

KX vs. modifier 22

Both are documentation-driven, but they solve opposite problems. Modifier 22 asks a contractor to pay more than the fee schedule amount because a single service was substantially harder than usual, and is priced by individual consideration. KX asks a contractor to pay the ordinary amount for a service that would otherwise be blocked by a coverage rule or threshold.

Where Jurisdiction Matters — More Here Than Anywhere Else

KX is the modifier most exposed to jurisdictional variation, because its content is defined by LCDs and contractor articles rather than by a national rule. The therapy threshold mechanism is national and statutory; almost everything else about KX is not. The four DME MACs publish their own LCD sets and documentation requirement articles, and the A/B MACs — Novitas, Noridian, First Coast Service Options, Palmetto GBA, WPS, CGS and others — differ in which local policies use KX at all, what evidence they expect, and how they handle an incorrectly-appended one.

Treat any specific “KX requires X” claim you encounter online as jurisdiction-scoped until you have confirmed it against the LCD or article that governs your claim. The reliable move is to open the current LCD (and its companion Local Coverage Article, which is usually where the documentation requirements live) rather than to rely on a general modifier reference. CASRAI’s guide to NCDs and LCDs covers how to find the instrument that applies.

Frequently Asked Questions

What does modifier KX actually mean?

That the requirements specified in the applicable medical policy have been met and the supporting documentation exists. It has no independent clinical content — the requirements come from whichever LCD, NCD, article or statutory threshold governs the item or service being billed.

When is KX required for outpatient therapy?

Once a beneficiary’s incurred therapy expenses for the year pass the KX modifier threshold, claims for further medically necessary services in that discipline pairing must carry KX. CMS lists the CY 2026 threshold as $2,480 for PT and SLP combined and $2,480 for OT. Because these amounts are indexed and updated annually, check the current CMS figure rather than relying on a remembered number.

Does appending KX guarantee payment?

No. It clears the specific edit or threshold that would otherwise block the line, and it moves the claim into a posture where medical necessity is assumed at adjudication rather than at submission. Post-payment review remains available, and the attestation is what gets examined.

Can KX and GA go on the same line?

They express contradictory positions — KX asserts the criteria are met, GA anticipates a medical-necessity denial — so combining them signals an unresolved coverage determination rather than a compliant claim. Resolve which is true before billing, and consult the specific payer’s edit logic if you believe an unusual case genuinely calls for both.

What happens if KX was appended incorrectly?

Outcomes range from an unprocessable return (in DMEPOS, commonly with remark code MA130, which carries no appeal rights and must be corrected and resubmitted) to a post-payment denial and overpayment recovery, to — where the attestation was knowingly false — exposure well beyond the claim itself. The Chapter 5 sanction language is explicit that an inaccurate attestation is treated as inaccurate information on a claim.

Is KX a CPT modifier?

No. KX is a HCPCS Level II modifier maintained within the CMS-administered HCPCS system, not a CPT modifier owned by the AMA. That distinction matters when you go looking for the authoritative definition: for KX it lives in CMS policy, not the CPT codebook.

Related CASRAI Resources

• Modifier 33 and modifier PT — including the colorectal screening scenario where KX carries a benefit-category meaning
• Modifier GA: waiver of liability and the ABN — the opposite posture on the same coverage question
• Advance Beneficiary Notice (ABN) mechanics
• Medicare coverage determinations: NCDs and LCDs — how to find the policy KX is attesting to
• Modifier 22: increased procedural services
• Modifier 24: unrelated E/M in the postoperative period
• The False Claims Act in billing
• Modifier 91: repeat clinical diagnostic laboratory test — another area where LCD frequency limits drive the decision
• The seven elements of an effective compliance program

Sources: CMS Medicare Claims Processing Manual, Publication 100-04, Chapter 5, Sections 10.2–10.3.4 (therapy thresholds and KX attestation) and Chapter 13 (PET oncologic processing); CMS therapy services guidance for the CY 2026 threshold amounts; Noridian Healthcare Solutions DME MAC modifier KX guidance and LCD list. Threshold dollar amounts are indexed and change annually — verify the current year before use. This page is general reference material, not coding advice for a specific claim.